A5069918903- Pharmaceutical Practices and Patient Outcomes
- Medication Adherence and Compliance
- Health Systems, Economic Evaluations, Quality of Life
- Patient Satisfaction in Healthcare
- Diabetes Management and Research
- Pharmaceutical Economics and Policy
- Diabetes Management and Education
- Pharmaceutical studies and practices
- Pharmaceutical industry and healthcare
- Patient Safety and Medication Errors
- Diabetes Treatment and Management
- Chronic Disease Management Strategies
- Innovations in Medical Education
- Diversity and Career in Medicine
- Medical Education and Admissions
- Healthcare Policy and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Medical Malpractice and Liability Issues
- Sex and Gender in Healthcare
- Pharmacy and Medical Practices
- Gender Diversity and Inequality
- HIV/AIDS Research and Interventions
- Primary Care and Health Outcomes
- Telemedicine and Telehealth Implementation
- Patient-Provider Communication in Healthcare
Ohio Northern University
2022-2024
University of Wyoming
2020
University of Iowa
2011
American College of Clinical Pharmacy
2011
Humana (United States)
2009-2010
University of Michigan
2002-2007
University of Kentucky
2006-2007
Medication Management (United States)
2004
West Virginia University
1998-2001
University of Florida Health
1997
OBJECTIVE—This study examines the association between oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes. RESEARCH DESIGN AND METHODS—Using administrative claims data (2000–2001) from a managed care organization in Midwestern U.S., this analyzed 900 enrollees, aged 18 years over, diabetes who were taking agents both but did not use insulin. Nonadherence was defined as possession ratio (MPR) <80%. Multivariate logistic...
OBJECTIVE: To evaluate the accordance between three measures of self-reported medication adherence. METHODS: A survey was administered to HIV patients. The adherence included a four-item Morisky-type scale (Measure1) and two defining as percentage doses taken prescribed during past days (Measure2) or weeks (Measure3). RESULTS: For Measure1, 29.2% patients were categorized high 61.5% medium Measure2 Measure3, mean scores 93.6% 96.5%, respectively. Using 90% cutoff values, 78.5% 95.4%...
AbstractBackground:Although visual analog scales (VAS) have been used frequently in outcomes research, there is little evidence regarding the validity of this scale for measuring medication adherence.Objective:To determine whether a VAS self-report measure adherence concordant with claims-based measurement adherence.Methods:A mail survey was conducted 2005 persons diabetes. Prescription claims were obtained 1985 respondents who oral diabetes medications and lipid-modifying drugs. The...
OBJECTIVES: Evaluate a community pharmacist-based diabetes patient-management program by examining the pharmacists' impact on five intermediate outcomes: glycosolated hemoglobin (HbA1c), blood pressure, body mass index, lipid levels, and medication use in patients with diabetes. SETTING: A network of pharmacies West Virginia southeastern Ohio. PATIENTS: The was available to all who attended regardless baseline glycemic control. Of 47 initially enrolled, 32 stayed for at least 6 months during...
The Medicare star ratings system incentivizes health plan sponsors based on their performance across a measurement that contains quality measures related to medication use. As seek further engage network providers, specifically pharmacies, improve these measures, it is important consider the effect of environmental factors pharmacies.To determine pharmacy as measured by (a) adherence for noninsulin diabetes medications, (b) renin angiotensin receptor antagonists (RASA), (c) cholesterol...
During the past several years, emphasis on quality in health care has been evolving. Alongside this evolution of change advancement clinical pharmacy services ambulatory settings. Although they share importance, both and have progressed moved their own directions. Nevertheless, today's evolving landscape, collaboration among providers, including pharmacists, must occur to enhance quality. Pharmacy improve be a sustainable service. This White Paper provides rationale structure that unite...
To evaluate the impact of a collaborative effort Medicare Advantage and prescription drug (MAPD) plan community pharmacies to improve vaccination rates for pneumonia influenza.This quasiexperimental, cluster-randomized intervention study used MAPD data assess pharmacists on rates. Pharmacies in specific regions (districts) were randomly assigned or control groups. Intervention received reports patients with gap influenza (aged 19-89 years) and/or pneumococcal 65-89 vaccinations based medical...